Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSmiths Group Regulatory News (SMIN)

Share Price Information for Smiths Group (SMIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,717.00
Bid: 1,712.00
Ask: 1,714.00
Change: 19.00 (1.12%)
Spread: 2.00 (0.117%)
Open: 1,699.00
High: 1,717.00
Low: 1,699.00
Prev. Close: 1,698.00
SMIN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Smiths Group appoints new Finance Director

1 May 2015 07:00

RNS Number : 9270L
Smiths Group PLC
01 May 2015
 



 

News Release

London, 1 May 2015

For immediate release

 

 

Smiths Group appoints new Finance Director

Smiths Group plc is pleased to announce the appointment of Chris O'Shea as its new Finance Director, effective from 18 September 2015. Chris, 41, is currently Chief Financial Officer of the FTSE-250 company Vesuvius plc, a global leader in molten metal flow engineering. He formerly held senior international finance posts in BG Group plc and Royal Dutch Shell plc.

 

As previously announced, Rob White will continue as Interim Chief Financial Officer until Chris takes up his new post. Rob White, who replaced Peter Turner when he stepped down as Finance Director last week, will return to his position as Vice President, Global Finance for Smiths Medical following his temporary assignment.

 

Chief Executive Philip Bowman said: "I am delighted to welcome Chris to Smiths. He arrives at an exciting time as we continue to invest in our Engineered for Growth programme to accelerate top-line performance. His strong finance skills and corporate experience of the engineering and multi-national energy sectors will greatly benefit our business."

 

Chris O'Shea said: "Smiths has been a byword for engineering excellence for more than 150 years and I am thrilled to be joining a global leader with ambitious growth plans across a comprehensive range of products and markets. I look forward to becoming part of Smiths exciting future and working with the team to deliver the growth initiatives."

 

Statutory and other disclosures

There are no directorships to disclose in respect of paragraph 9.6.13R (1) and no details to disclose in respect of paragraph 9.6.13R (2) to (6) of the Listing Rules.

 

Chris O'Shea's service contract, remuneration and benefits will be consistent with the Smiths Group directors' remuneration policy approved by shareholders at the Annual General Meeting in November 2014. A summary of the key terms is provided here and further detail will be set out in the Company's remuneration report following his appointment.

 

His base salary will be £495,000 and he will be eligible for an annual bonus of up to 150% of base salary, one third of which will be deferred into Smiths Group shares. He will also be eligible for an annual award under the company's LTIP of up to 250% of base salary. Additionally, he will receive a pension allowance of 25% of his base salary, private healthcare and other customary benefits worth c. £1,000 in total.

 

As a consequence of joining Smiths Group, Chris is expected to forfeit certain bonus and long term incentives from his current employer. In order to compensate him for that, he will (a) receive a one-off award over 71,938 Smiths Group shares vesting in equal instalments on the first and second anniversary of his start date with Smiths Group and (b) be entitled to a cash payment calculated by reference to the pro-rated 2015 annual bonus foregone in respect of his current employment.

 

Chris O'Shea's service contract requires 6 months' notice of termination by him and 12 months by the Company. The Company may also terminate his employment by making a payment in lieu of notice (PILON) equivalent to the value of his base salary and benefits set out above (including pension allowance but excluding bonus) in respect of any unserved period of notice. The service contract contains specific provisions enabling a reduction in any phased PILON payments in the event that he finds alternative employment during the notice period.

 

ENDS

 

 

Investor Relations

Peter Durman: +44 (0)20 7808 5535 / +44 7825 145336

 

Media Relations

Colin McSeveny: +44 (0)20 7808 5534

Anthony Cardew - Cardew Group: +44 (0)20 7930 0777 / +44 (0)7770 720389

 

 

Smiths Group

 

Smiths is a global technology company listed on the London Stock Exchange (SMIN) and operates a sponsored level one ADR programme (SMGZY). A world leader in the practical application of advanced technologies, Smiths Group delivers products and services for the threat & contraband detection, medical devices, energy and communications markets worldwide. Our products and services make the world safer, healthier and more productive. Smiths Group employs around 23,000 people in over 50 countries. For more information visit www.smiths.com.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAWGUQACUPAGAU
Date   Source Headline
20th Jun 20247:00 amRNSTransaction in Own Shares
19th Jun 20247:00 amRNSTransaction in Own Shares
18th Jun 20247:00 amRNSTransaction in Own Shares
17th Jun 20247:00 amRNSTransaction in Own Shares
14th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20247:00 amRNSTransaction in Own Shares
12th Jun 20247:00 amRNSTransaction in Own Shares
11th Jun 20247:00 amRNSTransaction in Own Shares
10th Jun 20247:00 amRNSTransaction in Own Shares
7th Jun 20247:00 amRNSTransaction in Own Shares
6th Jun 20247:00 amRNSTransaction in Own Shares
5th Jun 20247:00 amRNSTransaction in Own Shares
4th Jun 20247:00 amRNSTransaction in Own Shares
3rd Jun 20243:35 pmRNSTotal Voting Rights
3rd Jun 202410:00 amRNSDirectorate Change
3rd Jun 20247:00 amRNSTransaction in Own Shares
31st May 20247:00 amRNSTransaction in Own Shares
21st May 20247:00 amRNSSmiths Group 3rd Quarter Results
16th May 20249:30 amRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:45 pmRNSDirector/PDMR Shareholding
1st May 20243:30 pmRNSTotal Voting Rights
1st May 202410:00 amRNSBlock listing Interim Review
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20249:00 amRNSDirector/PDMR Shareholding
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20244:30 pmRNSTotal Voting Rights
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:15 amRNSShare buyback programme

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.